Table 2 Antimicrobial activity of B1, 23 and 26 against a collection of clinical isolates from canine (µg/mL).

From: Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections

Bacteria

B1

23

26

Acinetobacter baumannii, 27065, 16 D1, dog, wound, 2010

64

64

>64

Corynebacterium auriscanis, 31551, 54 C6, dog, ear, 2013

4

8

32

E. coli, 30235, 23 A6, dog, wound, 2012

64

32

32

Enterococcus faecalis, 27404, 17 C7, dog, wound, 2011

64

>64

64

Enterococcus faecium, 30951, 24 C1, dog, ear, 2013

16

64

>64

Klebsiella pneumoniae, 26233, 11 H5, dog, wound, 2010

>64

>64

>64

Pasteurella canis, 31096, 24 C8, dog, skin, 2013

8

>64

>64

Proteus mirabilis, 25178, 9 A4, dog, ear, 2009

>64

>64

>64

Pseudomonas aeruginosa (26314, 12 C5, dog, urine, 2010).

16

64

>64

Streptococcus canis, 26740-1, 14 H1, dog, ear, 2010

4

16

>64

Staphylococcus aureus, 27266, 16 G9, dog, skin, 2010

8

32

64

Staphylococcus pseudintermedius (22963, 3 B9, dog, 2007).

2

4

4